Nivolumab

Drug Class:	Commonly Known As:	Category:
Anti-PD-1 Monoclonal Antibody	Opdivo®	Cancer-related

Nivolumab - What is it for

Nivolumab belongs to a class of medications known as immunotherapy. It works with your body's immune system to fight against the tumour cells.

During infusion

Allergic reactions uncommonly develop during the first infusion. Symptoms may include chills, rigors, shortness of breath, chest discomfort, flushing or itch.
Alert your nurse if you experience any of the above during the infusion.

Other side effects (usually mild, may occur within a few weeks after 1st dose)

Please seek medical attention if any of the following occurs:

Signs of skin toxicity e.g. swelling, extensive peeling of skin, severe rashes etc.
Signs of liver/ gastrointestinal toxicity e.g. severe diarrhea, dark coloured urine, intense abdominal pain, yellowing of the skin or whites of eyes
Persistent shortness of breath or dry cough
Extreme fatigue, abnormal intolerance of cold or heat, feeling irritable
Unusual headache